combination therapies outperforming semaglutide Obesity treatment is evolving rapidly, with newer medications now offering significant and sustained weight loss when combined with lifestyle modification. GLP-1 and dual GIP/GLP-1 such as and tirzepatide are currently The FDA's Decision to Ban

Zhang L, et al

Our programs focus on sustainable lifestyle changes, ensuring your long-term health and well-being

These medications offer a promising avenue for weight loss, but they are most impactful when combined with a holistic approach to healthy habits

Essential Baseline Assessment Depending on the treatment indication and medical history, a baseline assessment may include: Hemoglobin A1C Glucose Test Comprehensive Metabolic Panel Lipid Panel Complete Blood Count when clinically appropriate Kidney Profile or urine albumin-to-creatinine testing for relevant diabetes or kidney risk Early Follow-Up Follow-up may be considered after treatment initiation, dose escalation, or a clinically meaningful change in symptoms